SCHEMBL23964191

SCHEMBL23964191

c1cnc2[nH]c(CN3CCN(c4ccncc4)CC3)cc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 11/20 0.61
DRD2 P14416 9/20 0.61
DRD3 P35462 9/20 0.61
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
HRH1 P35367 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
HTR1A P08908 3/20 0.45
ADRA2A P08913 2/20 0.45
ADRA2B P18089 2/20 0.45
ADRA2C P18825 2/20 0.45
OPRK1 P41145 1/20 0.45
HTR2A P28223 4/20 0.44
HTR7 P34969 3/20 0.44
HTR6 P50406 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
TSHR P16473 2/20 0.44
NFKB1 P19838 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040776 1.00 DRD4 (0.61) DRD4DRD2DRD3CCNE1CDK2
SCHEMBL4822169 0.91 DRD4 (0.63) DRD4DRD2DRD3CCNE1CDK2
SCHEMBL4822287 0.86 DRD4 (0.62) DRD4DRD2DRD3CCNE1CDK2
SCHEMBL4823457 0.82 DRD4 (0.65) DRD4DRD2DRD3HTR1AADRA2A
SCHEMBL23964200 0.82 HRH4 (0.63) DRD4DRD2DRD3HRH1HRH3
SCHEMBL30041451 0.82 HRH4 (0.63) DRD4DRD2DRD3HRH1HRH3
SCHEMBL857986 0.81 DRD2 (0.66) DRD4DRD2DRD3CCNE1CDK2
SCHEMBL23964346 0.80 DRD4 (0.47) DRD4DRD2DRD3HTR1AADRA2A
SCHEMBL4825047 0.80 HTR1A (0.59) DRD4DRD2DRD3HTR1AADRA2A
SCHEMBL23964189 0.80 DRD4 (0.51) DRD4DRD2DRD3HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 US disclosed
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 US disclosed
CN-115427404-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-12-02 CN disclosed
WO-2021216665-A9 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-02 WO disclosed
WO-2021216665-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF COL1A1, COL2A1, COL14A1 DRD4 4746/4885DRD2 4780/4885DRD3 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.